LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions
Authors
Keywords
Low-dose radiation (LDR), SKOV3/DDP cells, Cisplatin (DDP), Excision repair cross complementing-group 1 (ERCC1), B-Cell lymphoma 2 (Bcl-2), Survivin, Caspase-3
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 102, Issue -, Pages 549-554
Publisher
Elsevier BV
Online
2018-04-06
DOI
10.1016/j.biopha.2018.03.092

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.